Lucidigm Therapeutics
- Biotech or pharma, therapeutic R&D
Lucidigm is developing innovative immunomodulatory biologics for autoimmune disease, organ transplantation, and gene therapy. Our enzymes achieves immunomodulation through class-specific degradation of immunoglobulins, with an initial focus on IgM and IgG.
Address
North CarolinaUnited States
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}